• Chest · Dec 2024

    Review

    How I Do It: Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes.

    • Fariba M Donovan, George R Thompson, Janis E Blair, Royce H Johnson, Josh Malo, Waseem Albasha, Stephanie G Worrell, Staci E Beamer, Kavitha Yaddanapudi, John N Galgiani, and Neil M Ampel.
    • Valley Fever Center for Excellence, University of Arizona School of Medicine; Tucson, AZ, USA; Division of Infectious Diseases, Department of Internal Medicine, University of Arizona School of Medicine; Tucson, AZ, USA; The BIO5 Institute, University of Arizona, Tucson, AZ, USA. Electronic address: faribadonovan@arizona.edu.
    • Chest. 2024 Dec 13.

    AbstractCoccidioidomycosis (CM), caused by the dimorphic fungi Coccidioides immitis (C. immitis) and C. posadasii, is recognized as an increasing threat both nationally and worldwide. This is in large part secondary to the expanding range of Coccidioides spp. and increased international travel to endemic regions. The majority of individuals exposed to airborne Coccidioides organisms do not need medical attention, but approximately 30% will develop primary pulmonary coccidioidomycosis (PCM) with signs and symptoms that mimic community acquired pneumonia (CAP) or other respiratory illnesses. Further, 5% of those diagnosed will develop serious and even life-threatening manifestations including extrapulmonary/disseminated coccidioidomycosis (DCM). Of those who develop PCM, past evidence suggests ∼ 5% to 15% will develop long-term pulmonary sequelae in the form of nodules, abscesses, or cavitary lesions. These lesions may not be easily distinguished from malignancy or other infections, such as tuberculosis, and they add a substantial burden to both patients and the healthcare system. Despite the long-term consequences of cavitary CM in some individuals, the current literature review and practice guidelines demonstrate a paucity of clear management strategies to treat these patients. In this report we will focus on cavitary lesions in CM with the goal to present a description of the evaluation and management of their various forms, manifestations, and complications. These recommendations are derived from a multidisciplinary group of experts.Copyright © 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…